Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
May-2025 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2025 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs

  • Authors:
    • Shuai Zhou
    • Xinyuan Hu
    • Peiwen Zhou
    • Junzhuo Si
    • Yanfang Jiang
  • View Affiliations / Copyright

    Affiliations: Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
    Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 83
    |
    Published online on: March 11, 2025
       https://doi.org/10.3892/br.2025.1961
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Interindividual variability in drug metabolism serves a critical role in the occurrence of adverse drug reactions. Factors such as age, sex, body mass index (BMI) and liver and renal function can influence the metabolism of antipsychotic medications. To the best of our knowledge, however, clinical prediction models based on these factors for estimating drug‑metabolizing capacity have not yet been developed. Between January 2022 and September 2023, 185 adult patients (aged ≥18 years) who did not have cancer and were not critically ill, with or without comorbidities such diabetes, hypertension and liver and kidney diseases, who underwent pharmacogenetic testing at The First Hospital of Jilin University (Changchun, China) were enrolled. Clinical data were collected, and the participants were divided into training and validation cohorts. Logistic regression was performed to identify significant risk factors, which were incorporated into multivariable models to construct nomograms predicting psychotropic drug metabolism. A total of eight clinical indicators (BMI, hypertension, alkaline phosphatase, aspartate aminotransferase, cholinesterase, albumin to globulin ratio, urea, and uric acid) were significantly associated with psychotropic drug metabolism (all P<0.05). Based on these indicators, along with age and sex, prediction models for psychotropic drug metabolism were developed. The areas under the receiver operating characteristic curves for haloperidol, olanzapine, paroxetine, mirtazapine/venlafaxine and oxazepam/lorazepam in the validation dataset were 0.767, 0.767, 0.705, 0.740 and 0.789, respectively, indicating the models had moderate diagnostic efficiency. Nomograms were constructed to demonstrate the contribution of each indicator to drug metabolism capacity. To the best of our knowledge, the present study is the first to develop predictive models for psychotropic drug metabolism. These models offer clinicians practical tools to identify patients with impaired drug‑metabolizing capacity, thereby enabling more precise and personalized medication management.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Goff DC: The pharmacologic treatment of schizophrenia-2021. JAMA. 325:175–176. 2021.PubMed/NCBI View Article : Google Scholar

2 

Goff DC, Falkai P, Fleischhacker WW, Girgis RR, Kahn RM, Uchida H, Zhao J and Lieberman JA: The long-term effects of antipsychotic medication on clinical course in schizophrenia. Am J Psychiatry. 174:840–849. 2017.PubMed/NCBI View Article : Google Scholar

3 

Middeldorp CM, Cath DC, Van Dyck R and Boomsma DI: The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies. Psychol Med. 35:611–624. 2005.PubMed/NCBI View Article : Google Scholar

4 

Pardiñas AF, Owen MJ and Walters JTR: Pharmacogenomics: A road ahead for precision medicine in psychiatry. Neuron. 109:3914–3929. 2021.PubMed/NCBI View Article : Google Scholar

5 

Biso L, Aringhieri S, Carli M, Scarselli M and Longoni B: Therapeutic drug monitoring in psychiatry: Enhancing treatment precision and patient outcomes. Pharmaceuticals (Basel). 17(642)2024.PubMed/NCBI View Article : Google Scholar

6 

Phillips KA, Veenstra DL, Oren E, Lee JK and Sadee W: Potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review. JAMA. 286:2270–2279. 2001.PubMed/NCBI View Article : Google Scholar

7 

Solomon HV, Cates KW and Li KJ: Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions? Psychiatry Res. 271:604–613. 2019.PubMed/NCBI View Article : Google Scholar

8 

Chaplin M, Kirkham JJ, Dwan K, Sloan DJ, Davies G and Jorgensen AL: STrengthening the reporting of pharmacogenetic studies: Development of the STROPS guideline. PLoS Med. 17(e1003344)2020.PubMed/NCBI View Article : Google Scholar

9 

Verbelen M, Weale ME and Lewis CM: Cost-effectiveness of pharmacogenetic-guided treatment: Are we there yet? Pharmacogenomics J. 17:395–402. 2017.PubMed/NCBI View Article : Google Scholar

10 

Leitch TM, Killam SR, Brown KE, Katseanes KC, George KM, Schwanke C, Loveland J, Elias AF, Haney K, Krebsbach K, et al: Ensuring equity: Pharmacogenetic implementation in rural and tribal communities. Front Pharmacol. 13(953142)2022.PubMed/NCBI View Article : Google Scholar

11 

Kloosterboer SM, Egberts KM, de Winter BCM, van Gelder T, Gerlach M, Hillegers MHJ, Dieleman GC, Bahmany S, Reichart CG, van Daalen E, et al: Pipamperone population pharmacokinetics related to effectiveness and side effects in children and adolescents. Clin Pharmacokinet. 59:1393–1405. 2020.PubMed/NCBI View Article : Google Scholar

12 

Hassab Errasoul A and Alarabi MA: Factors predicting serum clozapine levels in Middle Eastern patients: An observational study. BMC Psychiatry. 22(269)2022.PubMed/NCBI View Article : Google Scholar

13 

Sun L, von Moltke L and Rowland Yeo K: Application of physiologically based pharmacokinetic modeling to predict the effect of renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination. Clin Pharmacokinet. 60:637–647. 2021.PubMed/NCBI View Article : Google Scholar

14 

Li XL, Huang SQ, Xiao T, Wang XP, Kong W, Liu SJ, Zhang Z, Yang Y, Huang SS, Ni XJ, et al: Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients. Front Pharmacol. 13(966622)2022.PubMed/NCBI View Article : Google Scholar

15 

Lin S, Zhu N, YihanZhang Du L and Zhang S: Development and validation of a prediction model of catheter-related thrombosis in patients with cancer undergoing chemotherapy based on ultrasonography results and clinical information. J Thromb Thrombolysis. 54:480–491. 2022.PubMed/NCBI View Article : Google Scholar

16 

Jin H, Shen X, Song W, Liu Y, Qi L and Zhang F: The development of nomograms to predict blastulation rate following cycles of in vitro fertilization in patients with tubal factor infertility, polycystic ovary syndrome, or endometriosis. Front Endocrinol (Lausanne). 12(751373)2021.PubMed/NCBI View Article : Google Scholar

17 

Chen C and Lu FC: Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 17 (Suppl):S1–S36. 2004.PubMed/NCBI

18 

National Health Commission of the People's Republic of China: WS/T 404.1-2012 Reference Intervals for Common Clinical Biochemical Tests-Part 1. China Standards Press, Beijing, 2012.

19 

National Health Commission of the People's Republic of China: WS/T 404.2-2012 Reference Intervals for Common Clinical Biochemical Tests-Part 2. China Standards Press, Beijing, 2012.

20 

National Health Commission of the People's Republic of China: WS/T 404.4-2012 Reference Intervals for Common Clinical Biochemical Tests-Part 4. China Standards Press, Beijing, 2012.

21 

National Health Commission of the People's Republic of China: WS/T 404.6-2012 Reference Intervals for Common Clinical Biochemical Tests-Part 6. China Standards Press, Beijing, 2012.

22 

Rajman I, Knapp L, Morgan T and Masimirembwa C: African genetic diversity: Implications for cytochrome P450-mediated drug metabolism and drug development. EBioMedicine. 17:67–74. 2017.PubMed/NCBI View Article : Google Scholar

23 

Song C, Yu D, Wang Y, Wang Q, Guo Z, Huang J, Li S and Hu W: Dual primary cancer patients with lung cancer as a second primary malignancy: A population-based study. Front Oncol. 10(515606)2020.PubMed/NCBI View Article : Google Scholar

24 

Wang S, Tian S, Li Y, Zhan N, Guo Y, Liu Y, Xu J, Ma Y, Zhang S, Song S, et al: Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion. EBioMedicine. 58(102924)2020.PubMed/NCBI View Article : Google Scholar

25 

Lozupone M, Panza F, Stella E, La Montagna M, Bisceglia P, Miscio G, Galizia I, Daniele A, di Mauro L, Bellomo A, et al: Pharmacogenetics of neurological and psychiatric diseases at older age: Has the time come? Expert Opin Drug Metab Toxicol. 13:259–277. 2017.PubMed/NCBI View Article : Google Scholar

26 

Gomez A and Ingelman-Sundberg M: Epigenetic and microRNA-dependent control of cytochrome P450 expression: A gap between DNA and protein. Pharmacogenomics. 10:1067–1076. 2009.PubMed/NCBI View Article : Google Scholar

27 

Seripa D, Panza F, Daragjati J, Paroni G and Pilotto A: Measuring pharmacogenetics in special groups: Geriatrics. Expert Opin Drug Metab Toxicol. 11:1073–1088. 2015.PubMed/NCBI View Article : Google Scholar

28 

Bies RR, Feng Y, Lotrich FE, Kirshner MA, Roose S, Kupfer DJ and Pollock BG: Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects. J Clin Pharmacol. 44:1352–1359. 2004.PubMed/NCBI View Article : Google Scholar

29 

Dhillon S, Scott LJ and Plosker GL: Escitalopram: A review of its use in the management of anxiety disorders. CNS Drugs. 20:763–790. 2006.PubMed/NCBI View Article : Google Scholar

30 

Jin Y, Pollock BG, Frank E, Cassano GB, Rucci P, Müller DJ, Kennedy JL, Forgione RN, Kirshner M, Kepple G, et al: Effect of age, weight, and CYP2C19 genotype on escitalopram exposure. J Clin Pharmacol. 50:62–72. 2010.PubMed/NCBI View Article : Google Scholar

31 

Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I and Brockmöller J: Pharmacogenetics of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response. Mol Psychiatry. 9:442–473. 2004.PubMed/NCBI View Article : Google Scholar

32 

Richards-Belle A, Austin-Zimmerman I, Wang B, Zartaloudi E, Cotic M, Gracie C, Saadullah Khani N, Wannasuphoprasit Y, Wronska M, Dawda Y, et al: Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19/CYP2D6 genes play a role? A UK population-based study. J Psychopharmacol. 37:396–407. 2023.PubMed/NCBI View Article : Google Scholar

33 

Zanger UM and Schwab M: Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138:103–141. 2013.PubMed/NCBI View Article : Google Scholar

34 

Austin-Zimmerman I, Wronska M, Wang B, Irizar H, Thygesen JH, Bhat A, Denaxas S, Fatemifar G, Finan C, Harju-Seppänen J, et al: The influence of CYP2D6 and CYP2C19 genetic variation on diabetes mellitus risk in people taking antidepressants and antipsychotics. Genes (Basel). 12(1758)2021.PubMed/NCBI View Article : Google Scholar

35 

Hägg S, Spigset O and Dahlqvist R: Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers. Br J Clin Pharmacol. 51:169–173. 2001.PubMed/NCBI View Article : Google Scholar

36 

Meibohm B, Beierle I and Derendorf H: How important are gender differences in pharmacokinetics? Clin Pharmacokinet. 41:329–342. 2002.PubMed/NCBI View Article : Google Scholar

37 

Maatouk I, Herzog W, Böhlen F, Quinzler R, Löwe B, Saum KU, Brenner H and Wild B: Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. J Hypertens. 34:1711–1720. 2016.PubMed/NCBI View Article : Google Scholar

38 

Castberg I, Westin AA, Skogvoll E and Spigset O: Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine. Acta Psychiatr Scand. 136:455–464. 2017.PubMed/NCBI View Article : Google Scholar

39 

Shah RR: Drug development and use in the elderly: Search for the right dose and dosing regimen (parts I and II). Br J Clin Pharmacol. 58:452–469. 2004.PubMed/NCBI View Article : Google Scholar

40 

Black CN, Bot M, Scheffer PG, Cuijpers P and Penninx BW: Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology. 51:164–175. 2015.PubMed/NCBI View Article : Google Scholar

41 

Chaudhari K, Khanzode S, Khanzode S, Dakhale G, Saoji A and Sarode S: Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder. Indian J Clin Biochem. 25:77–81. 2010.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhou S, Hu X, Zhou P, Si J and Jiang Y: Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs. Biomed Rep 22: 83, 2025.
APA
Zhou, S., Hu, X., Zhou, P., Si, J., & Jiang, Y. (2025). Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs. Biomedical Reports, 22, 83. https://doi.org/10.3892/br.2025.1961
MLA
Zhou, S., Hu, X., Zhou, P., Si, J., Jiang, Y."Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs". Biomedical Reports 22.5 (2025): 83.
Chicago
Zhou, S., Hu, X., Zhou, P., Si, J., Jiang, Y."Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs". Biomedical Reports 22, no. 5 (2025): 83. https://doi.org/10.3892/br.2025.1961
Copy and paste a formatted citation
x
Spandidos Publications style
Zhou S, Hu X, Zhou P, Si J and Jiang Y: Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs. Biomed Rep 22: 83, 2025.
APA
Zhou, S., Hu, X., Zhou, P., Si, J., & Jiang, Y. (2025). Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs. Biomedical Reports, 22, 83. https://doi.org/10.3892/br.2025.1961
MLA
Zhou, S., Hu, X., Zhou, P., Si, J., Jiang, Y."Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs". Biomedical Reports 22.5 (2025): 83.
Chicago
Zhou, S., Hu, X., Zhou, P., Si, J., Jiang, Y."Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs". Biomedical Reports 22, no. 5 (2025): 83. https://doi.org/10.3892/br.2025.1961
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team